메뉴 건너뛰기




Volumn 194, Issue 8, 2015, Pages 3829-3839

Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic amp-protein kinase a and inflammasome-dependent IL-1 signaling

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 1 INHIBITOR; CASPASE INHIBITOR; CHOLERA TOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE A; DOUBLE MUTANT HEAT LABILE TOXIN; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA CONVERTING ENZYME; MULTIPLE MUTATED CHOLERA TOXIN; STAPHYLOCOCCUS ENTEROTOXIN B; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CALCIUM BINDING PROTEIN; CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CYCLIC AMP; IL1B PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1BETA; NLRC4 PROTEIN, HUMAN; NLRP1 PROTEIN, HUMAN; NLRP3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

EID: 84927646951     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401633     Document Type: Article
Times cited : (61)

References (49)
  • 1
    • 14744303986 scopus 로고    scopus 로고
    • Mucosal adjuvants
    • Freytag, L. C., and J. D. Clements. 2005. Mucosal adjuvants. Vaccine 23:1804-1813.
    • (2005) Vaccine , vol.23 , pp. 1804-1813
    • Freytag, L.C.1    Clements, J.D.2
  • 3
    • 77958195796 scopus 로고    scopus 로고
    • Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins
    • Lycke, N., and M. Bemark. 2010. Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins. Mucosal Immunol. 3:556-566.
    • (2010) Mucosal Immunol. , vol.3 , pp. 556-566
    • Lycke, N.1    Bemark, M.2
  • 4
    • 79954535010 scopus 로고    scopus 로고
    • Characterization of a mutant Escherichia coli heat-labile toxin, LT (R192G/L211A), as a safe and effective oral adjuvant
    • Norton, E. B., L. B. Lawson, L. C. Freytag, and J. D. Clements. 2011. Characterization of a mutant Escherichia coli heat-labile toxin, LT (R192G/L211A), as a safe and effective oral adjuvant. Clin. Vaccine Immunol. 18:546-551.
    • (2011) Clin. Vaccine Immunol. , vol.18 , pp. 546-551
    • Norton, E.B.1    Lawson, L.B.2    Freytag, L.C.3    Clements, J.D.4
  • 6
    • 74149085715 scopus 로고    scopus 로고
    • Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin
    • Summerton, N. A., R. W. Welch, L. Bondoc, H. H. Yang, B. Pleune, N. Ramachandran, A. M. Harris, D. Bland, W. J. Jackson, S. Park, et al. 2010. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin. Vaccine 28:1404-1411.
    • (2010) Vaccine , vol.28 , pp. 1404-1411
    • Summerton, N.A.1    Welch, R.W.2    Bondoc, L.3    Yang, H.H.4    Pleune, B.5    Ramachandran, N.6    Harris, A.M.7    Bland, D.8    Jackson, W.J.9    Park, S.10
  • 7
    • 84877034427 scopus 로고    scopus 로고
    • Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant
    • Holmgren, J., L. Bourgeois, N. Carlin, J. Clements, B. Gustafsson, A. Lundgren, E. Nygren, J. Tobias, R. Walker, and A. M. Svennerholm. 2013. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine 31:2457-2464.
    • (2013) Vaccine , vol.31 , pp. 2457-2464
    • Holmgren, J.1    Bourgeois, L.2    Carlin, N.3    Clements, J.4    Gustafsson, B.5    Lundgren, A.6    Nygren, E.7    Tobias, J.8    Walker, R.9    Svennerholm, A.M.10
  • 8
    • 84877795556 scopus 로고    scopus 로고
    • A double mutant heat-labile toxin from Escherichia coli, LT (R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection
    • Sjökvist Ottsjö, L., C. F. Flach, J. Clements, J. Holmgren, and S. Raghavan. 2013. A double mutant heat-labile toxin from Escherichia coli, LT (R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection. Infect. Immun. 81:1532-1540.
    • (2013) Infect. Immun. , vol.81 , pp. 1532-1540
    • Sjökvist Ottsjö, L.1    Flach, C.F.2    Clements, J.3    Holmgren, J.4    Raghavan, S.5
  • 9
    • 84886731020 scopus 로고    scopus 로고
    • Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli
    • El-Kamary, S. S., M. B. Cohen, A. L. Bourgeois, L. Van De Verg, N. Bauers, M. Reymann, M. F. Pasetti, and W. H. Chen. 2013. Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli. Clin. Vaccine Immunol. 20:1764-1770.
    • (2013) Clin. Vaccine Immunol. , vol.20 , pp. 1764-1770
    • El-Kamary, S.S.1    Cohen, M.B.2    Bourgeois, A.L.3    Van De Verg, L.4    Bauers, N.5    Reymann, M.6    Pasetti, M.F.7    Chen, W.H.8
  • 10
    • 84915775542 scopus 로고    scopus 로고
    • Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study
    • Lundgren, A., L. Bourgeois, N. Carlin, J. Clements, B. Gustafsson, M. Hartford, J. Holmgren, M. Petzold, R. Walker, and A.-M. Svennerholm. 2014. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study. Vaccine 32:7077-7084.
    • (2014) Vaccine , vol.32 , pp. 7077-7084
    • Lundgren, A.1    Bourgeois, L.2    Carlin, N.3    Clements, J.4    Gustafsson, B.5    Hartford, M.6    Holmgren, J.7    Petzold, M.8    Walker, R.9    Svennerholm, A.-M.10
  • 12
    • 79953005700 scopus 로고    scopus 로고
    • Cholera toxin - A foe & a friend
    • Sanchez, J., and J. Holmgren. 2011. Cholera toxin - a foe & a friend. Indian J. Med. Res. 133:153-163.
    • (2011) Indian J. Med. Res. , vol.133 , pp. 153-163
    • Sanchez, J.1    Holmgren, J.2
  • 14
    • 0031802314 scopus 로고    scopus 로고
    • Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli
    • Douce, G., M. M. Giuliani, V. Giannelli, M. G. Pizza, R. Rappuoli, and G. Dougan. 1998. Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli. Vaccine 16:1065-1073.
    • (1998) Vaccine , vol.16 , pp. 1065-1073
    • Douce, G.1    Giuliani, M.M.2    Giannelli, V.3    Pizza, M.G.4    Rappuoli, R.5    Dougan, G.6
  • 15
    • 65449133249 scopus 로고    scopus 로고
    • Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes
    • Negri, D. R., D. Pinto, S. Vendetti, M. Patrizio, M. Sanchez, A. Riccomi, P. Ruggiero, G. Del Giudice, and M. T. De Magistris. 2009. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes. Infect. Immun. 77:1924-1935.
    • (2009) Infect. Immun. , vol.77 , pp. 1924-1935
    • Negri, D.R.1    Pinto, D.2    Vendetti, S.3    Patrizio, M.4    Sanchez, M.5    Riccomi, A.6    Ruggiero, P.7    Del Giudice, G.8    De Magistris, M.T.9
  • 16
    • 84879243447 scopus 로고    scopus 로고
    • Th17 cell based vaccines in mucosal immunity
    • Kumar, P., K. Chen, and J. K. Kolls. 2013. Th17 cell based vaccines in mucosal immunity. Curr. Opin. Immunol. 25:373-380.
    • (2013) Curr. Opin. Immunol. , vol.25 , pp. 373-380
    • Kumar, P.1    Chen, K.2    Kolls, J.K.3
  • 18
    • 84875473675 scopus 로고    scopus 로고
    • Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses
    • Hirota, K., J. E. Turner, M. Villa, J. H. Duarte, J. Demengeot, O. M. Steinmetz, and B. Stockinger. 2013. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat. Immunol. 14:372-379.
    • (2013) Nat. Immunol. , vol.14 , pp. 372-379
    • Hirota, K.1    Turner, J.E.2    Villa, M.3    Duarte, J.H.4    Demengeot, J.5    Steinmetz, O.M.6    Stockinger, B.7
  • 19
    • 84871417768 scopus 로고    scopus 로고
    • The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens
    • Leach, S., J. D. Clements, J. Kaim, and A. Lundgren. 2012. The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens. PLoS ONE 7:e51718.
    • (2012) PLoS ONE , vol.7 , pp. e51718
    • Leach, S.1    Clements, J.D.2    Kaim, J.3    Lundgren, A.4
  • 20
    • 79959875101 scopus 로고    scopus 로고
    • Interleukin-23 and T helper 17-type responses in intestinal inflammation: From cytokines to T-cell plasticity
    • Morrison, P. J., S. J. Ballantyne, and M. C. Kullberg. 2011. Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology 133:397-408.
    • (2011) Immunology , vol.133 , pp. 397-408
    • Morrison, P.J.1    Ballantyne, S.J.2    Kullberg, M.C.3
  • 21
    • 34548125305 scopus 로고    scopus 로고
    • Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells
    • Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-949.
    • (2007) Nat. Immunol. , vol.8 , pp. 942-949
    • Acosta-Rodriguez, E.V.1    Napolitani, G.2    Lanzavecchia, A.3    Sallusto, F.4
  • 24
    • 62649139025 scopus 로고    scopus 로고
    • Immunological and inflammatory functions of the interleukin-1 family
    • Dinarello, C. A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27:519-550.
    • (2009) Annu. Rev. Immunol. , vol.27 , pp. 519-550
    • Dinarello, C.A.1
  • 26
    • 0025735374 scopus 로고
    • Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro
    • Bromander, A., J. Holmgren, and N. Lycke. 1991. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:2908-2914.
    • (1991) J. Immunol. , vol.146 , pp. 2908-2914
    • Bromander, A.1    Holmgren, J.2    Lycke, N.3
  • 27
    • 0037378940 scopus 로고    scopus 로고
    • Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development
    • Eriksson, K., M. Fredriksson, I. Nordström, and J. Holmgren. 2003. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect. Immun. 71:1740-1747.
    • (2003) Infect. Immun. , vol.71 , pp. 1740-1747
    • Eriksson, K.1    Fredriksson, M.2    Nordström, I.3    Holmgren, J.4
  • 28
    • 79956215858 scopus 로고    scopus 로고
    • Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production
    • Brereton, C. F., C. E. Sutton, P. J. Ross, Y. Iwakura, M. Pizza, R. Rappuoli, E. C. Lavelle, and K. H. Mills. 2011. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. J. Immunol. 186:5896-5906.
    • (2011) J. Immunol. , vol.186 , pp. 5896-5906
    • Brereton, C.F.1    Sutton, C.E.2    Ross, P.J.3    Iwakura, Y.4    Pizza, M.5    Rappuoli, R.6    Lavelle, E.C.7    Mills, K.H.8
  • 29
    • 84878237993 scopus 로고    scopus 로고
    • Activation and regulation of the inflammasomes
    • Latz, E., T. S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13:397-411.
    • (2013) Nat. Rev. Immunol. , vol.13 , pp. 397-411
    • Latz, E.1    Xiao, T.S.2    Stutz, A.3
  • 31
    • 60749104683 scopus 로고    scopus 로고
    • The inflammasome: A caspase-1-activation platform that regulates immune responses and disease pathogenesis
    • Franchi, L., T. Eigenbrod, R. Muñoz-Planillo, and G. Nuñez. 2009. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 10:241-247.
    • (2009) Nat. Immunol. , vol.10 , pp. 241-247
    • Franchi, L.1    Eigenbrod, T.2    Muñoz-Planillo, R.3    Nuñez, G.4
  • 32
    • 0015970615 scopus 로고
    • Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation
    • Holmgren, J., L. Lindholm, and I. Lönnroth. 1974. Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation. J. Exp. Med. 139:801-819.
    • (1974) J. Exp. Med. , vol.139 , pp. 801-819
    • Holmgren, J.1    Lindholm, L.2    Lönnroth, I.3
  • 33
    • 79959271214 scopus 로고    scopus 로고
    • Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
    • Hoechst, B., J. Gamrekelashvili, M. P. Manns, T. F. Greten, and F. Korangy. 2011. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 117:6532-6541.
    • (2011) Blood , vol.117 , pp. 6532-6541
    • Hoechst, B.1    Gamrekelashvili, J.2    Manns, M.P.3    Greten, T.F.4    Korangy, F.5
  • 34
    • 79952284706 scopus 로고    scopus 로고
    • Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells
    • Veglia, F., E. Sciaraffia, A. Riccomi, D. Pinto, D. R. Negri, M. T. De Magistris, and S. Vendetti. 2011. Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells. Infect. Immun. 79:1300-1310.
    • (2011) Infect. Immun. , vol.79 , pp. 1300-1310
    • Veglia, F.1    Sciaraffia, E.2    Riccomi, A.3    Pinto, D.4    Negri, D.R.5    De Magistris, M.T.6    Vendetti, S.7
  • 36
    • 79251469365 scopus 로고    scopus 로고
    • Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: An important role for interleukin-17 during the effector phase
    • Flach, C. F., A. K. Östberg, A. T. Nilsson, Rde. W. Malefyt, and S. Raghavan. 2011. Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase. Infect. Immun. 79:879-886.
    • (2011) Infect. Immun. , vol.79 , pp. 879-886
    • Flach, C.F.1    Östberg, A.K.2    Nilsson, A.T.3    Rde. Malefyt, W.4    Raghavan, S.5
  • 37
    • 0024493771 scopus 로고
    • Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo
    • Lycke, N., A. K. Bromander, L. Ekman, U. Karlsson, and J. Holmgren. 1989. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J. Immunol. 142:20-27.
    • (1989) J. Immunol. , vol.142 , pp. 20-27
    • Lycke, N.1    Bromander, A.K.2    Ekman, L.3    Karlsson, U.4    Holmgren, J.5
  • 39
    • 77954521853 scopus 로고    scopus 로고
    • Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling
    • Toma, C., N. Higa, Y. Koizumi, N. Nakasone, Y. Ogura, A. J. McCoy, L. Franchi, S. Uematsu, J. Sagara, S. Taniguchi, et al. 2010. Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-kappa B signaling. J. Immunol. 184:5287-5297.
    • (2010) J. Immunol. , vol.184 , pp. 5287-5297
    • Toma, C.1    Higa, N.2    Koizumi, Y.3    Nakasone, N.4    Ogura, Y.5    McCoy, A.J.6    Franchi, L.7    Uematsu, S.8    Sagara, J.9    Taniguchi, S.10
  • 40
    • 45849102043 scopus 로고    scopus 로고
    • ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way
    • Piccini, A., S. Carta, S. Tassi, D. Lasiglié, G. Fossati, and A. Rubartelli. 2008. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci. USA 105:8067-8072.
    • (2008) Proc. Natl. Acad. Sci. USA , vol.105 , pp. 8067-8072
    • Piccini, A.1    Carta, S.2    Tassi, S.3    Lasiglié, D.4    Fossati, G.5    Rubartelli, A.6
  • 41
    • 17144410317 scopus 로고    scopus 로고
    • Cholera toxin potentiates influences of IFN-gamma through activation of NF-kappaB and release of tumor necrosis factor-alpha
    • Blumberg, R. S., R. S. Pitman, C. T. Taylor, and S. P. Colgan. 2005. Cholera toxin potentiates influences of IFN-gamma through activation of NF-kappaB and release of tumor necrosis factor-alpha. J. Interferon Cytokine Res. 25:209-219.
    • (2005) J. Interferon Cytokine Res. , vol.25 , pp. 209-219
    • Blumberg, R.S.1    Pitman, R.S.2    Taylor, C.T.3    Colgan, S.P.4
  • 42
    • 84885741245 scopus 로고    scopus 로고
    • Cholera toxin breakdowns oral tolerance via activation of canonical NF-kB
    • Kim, K. J., H. A. Kim, K. H. Seo, H. K. Lee, B. Y. Kang, and S. Y. Im. 2013. Cholera toxin breakdowns oral tolerance via activation of canonical NF-kB. Cell. Immunol. 285:92-99.
    • (2013) Cell. Immunol. , vol.285 , pp. 92-99
    • Kim, K.J.1    Kim, H.A.2    Seo, K.H.3    Lee, H.K.4    Kang, B.Y.5    Im, S.Y.6
  • 43
    • 0036025166 scopus 로고    scopus 로고
    • Inhibition of the NF-kappaB transcriptional activity by protein kinase A
    • Takahashi, N., T. Tetsuka, H. Uranishi, and T. Okamoto. 2002. Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur. J. Biochem. 269:4559-4565.
    • (2002) Eur. J. Biochem. , vol.269 , pp. 4559-4565
    • Takahashi, N.1    Tetsuka, T.2    Uranishi, H.3    Okamoto, T.4
  • 44
    • 12344254849 scopus 로고    scopus 로고
    • Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors
    • Minguet, S., M. Huber, L. Rosenkranz, W. W. Schamel, M. Reth, and T. Brummer. 2005. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur. J. Immunol. 35:31-41.
    • (2005) Eur. J. Immunol. , vol.35 , pp. 31-41
    • Minguet, S.1    Huber, M.2    Rosenkranz, L.3    Schamel, W.W.4    Reth, M.5    Brummer, T.6
  • 45
    • 0027332925 scopus 로고
    • Activation of NF-kappa B by cAMP in human myeloid cells
    • Serkkola, E., and M. Hurme. 1993. Activation of NF-kappa B by cAMP in human myeloid cells. FEBS Lett. 334:327-330.
    • (1993) FEBS Lett. , vol.334 , pp. 327-330
    • Serkkola, E.1    Hurme, M.2
  • 46
    • 0032039076 scopus 로고    scopus 로고
    • Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300
    • Zhong, H., R. E. Voll, and S. Ghosh. 1998. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1:661-671.
    • (1998) Mol. Cell , vol.1 , pp. 661-671
    • Zhong, H.1    Voll, R.E.2    Ghosh, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.